Position in CDNA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$227,430
-$181,172 QoQ
Shares Held
7,980
-66.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#162
of 225 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026State of Wyoming holds $9,049,964 across 23 Diagnostics & Research names. CDNA ranks #10 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
22,228 | $3,861,225 | |
| 2 | SHC |
Sotera Health Co
|
56,651 | $1,005,555 | |
| 3 | MYGN |
Myriad Genetics Inc
|
107,783 | $615,440 | |
| 4 | GH |
Guardant Health, Inc.
|
2,620 | $393,078 | |
| 5 | VCYT |
Veracyte, Inc.
|
6,192 | $363,656 | |
| 6 | NEO |
Neogenomics Inc
|
19,811 | $289,042 | |
| 7 | GRAL |
GRAIL, Inc.
|
3,982 | $271,851 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,196 | $271,240 |
All Filings in CDNA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,430 | 7,980 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $408,602 | 23,537 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $155,486 | 8,253 | Shares | Sole | 2026-02-11 | |
| 2024-12-31 | $90,521 | 4,228 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $210,868 | 19,912 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $125,076 | 10,423 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $80,304 | 11,472 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $84,532 | 9,945 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,182 | 2,427 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $36,286 | 2,132 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||